<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="87713d73-5dcc-4158-8890-60efdbd28c05"><labelDrug name="Vaprisol"><Normalization><mmtx cui="C1698656" preferredWord="Vaprisol" semType="phsu, orch"/></Normalization></labelDrug><generic name="conivaptan hydrochloride"/><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.1" text="Drug Label for drug brand Vaprisol, containing conivaptan hydrochloride." type="negative"><entity charOffset="26:34" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.1.e.0" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="Drug Label for drug brand Vaprisol," preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><entity charOffset="47:71" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.1.e.1" text="conivaptan hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C1700196" phraseText="conivaptan hydrochloride." preferredWord="Conivaptan hydrochloride" semType="phsu, orch"/><RxNorm RxCui="1294548"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.1.e.2" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Vaprisol," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.1.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.1.e.1"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.1.e.2" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.1.e.0"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.1.e.2" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.1.e.1"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.14" text="If serum sodium is not rising at the desired rate, VAPRISOL may be titrated upward to a dose of 40 mg daily, administered in a continuous intravenous infusion." type="negative"><entity charOffset="9:15" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.14.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="serum sodium" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="51:59" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.14.e.1" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.14.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.14.e.1"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.17" text="Patients receiving VAPRISOL must have frequent monitoring of serum sodium and volume status. " type="negative"><entity charOffset="67:73" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.17.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="frequent monitoring of serum sodium" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="19:27" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.17.e.1" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.17.e.1" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.17.e.0"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.19" text="For patients who develop an undesirably rapid rate of rise of serum sodium, VAPRISOL should be discontinued, and serum sodium and neurologic status should be carefully monitored. " type="negative"><entity charOffset="68:74" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.19.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="an undesirably rapid rate of rise of serum sodium," preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="76:84" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.19.e.1" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><entity charOffset="119:125" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.19.e.2" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="serum sodium" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.19.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.19.e.1"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.19.e.1" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.19.e.2"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.20" text="If the serum sodium continues to rise, VAPRISOL should not be resumed. " type="negative"><entity charOffset="39:47" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.20.e.0" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><entity charOffset="13:19" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.20.e.1" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="the serum sodium" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.20.e.1" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.20.e.0"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.21" text="If hyponatremia persists or recurs, and the patient has had no evidence of neurologic sequelae of rapid rise in serum sodium, VAPRISOL may be resumed at a reduced dose see Warnings and Precautions (5.2). " type="negative"><entity charOffset="118:124" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.21.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="in serum sodium," preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="126:134" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.21.e.1" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.21.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.21.e.1"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.26" text="VAPRISOL is supplied in a single-use 100 mL flexible INTRAVIA Container containing a sterile premixed dilute, ready-to-use, nonpyrogenic solution of conivaptan hydrochloride, 0.2 mg per mL (20 mg/100 mL) in 5% Dextrose. " type="negative"><entity charOffset="149:173" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.26.e.0" text="conivaptan hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C1700196" phraseText="of conivaptan hydrochloride," preferredWord="Conivaptan hydrochloride" semType="phsu, orch"/><RxNorm RxCui="1294548"/></Normalization></entity><entity charOffset="207:218" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.26.e.1" text="5 dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0985452" phraseText="in 5% Dextrose." preferredWord="Glucose 50 MG/ML" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.26.e.2" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.26.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.26.e.1"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.26.e.2" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.26.e.0"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.26.e.2" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.26.e.1"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.28" text="VAPRISOL is compatible with 5% Dextrose Injection. " type="negative"><entity charOffset="28:39" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.28.e.0" text="5 dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0985452" phraseText="compatible with 5% Dextrose Injection." preferredWord="Glucose 50 MG/ML" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.28.e.1" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.28.e.1" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.28.e.0"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.29" text="VAPRISOL is physically and chemically compatible with 0.9% Sodium Chloride Injection for up to 48 hours when the two solutions are co-administered via a Y-site connection at a flow rate for VAPRISOL of 4.2 mL/hour and at flow rates for 0.9% Sodium Chloride Injection of either 2.1 mL/hour or 6.3 mL/hour." type="negative"><entity charOffset="190:198" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.29.e.0" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="for VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><entity charOffset="236:266" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.29.e.1" text="0.9 sodium chloride injection" type="Biomedical_Entity"><Normalization><mmtx cui="C0980221" phraseText="for 0.9% Sodium Chloride Injection" preferredWord="Sodium Chloride 0.154 MEQ/ML Injectable Solution" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="54:84" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.29.e.2" text="0.9 sodium chloride injection" type="Biomedical_Entity"><Normalization><mmtx cui="C0980221" phraseText="chemically compatible with 0.9% Sodium Chloride Injection" preferredWord="Sodium Chloride 0.154 MEQ/ML Injectable Solution" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.29.e.3" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.29.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.29.e.1"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.29.e.2" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.29.e.0"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.29.e.3" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.29.e.1"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.29.e.3" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.29.e.2"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.30" text="VAPRISOL has been shown to be incompatible with both Lactated Ringer's Injection and furosemide injection when these products are mixed in the same container, therefore, do not combine VAPRISOL with these products in the same intravenous line or container." type="negative"><entity charOffset="185:193" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.30.e.0" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL with these products" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><entity charOffset="85:105" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.30.e.1" text="furosemide injection" type="Biomedical_Entity"><Normalization><mmtx cui="C0309152" phraseText="furosemide injection" preferredWord="Furosemide Injectable Solution" semType="clnd"/><RxNorm RxCui="4603"/></Normalization></entity><entity charOffset="53:80" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.30.e.2" text="lactated ringer's injection" type="Biomedical_Entity"><Normalization><mmtx cui="C0140600" phraseText="incompatible with both Lactated Ringer's Injection" preferredWord="Calcium Chloride 0.0014 MEQ/ML / Potassium Chloride 0.004 MEQ/ML / Sodium Chloride 0.103 MEQ/ML / Sodium Lactate 0.028 MEQ/ML Injectable Solution" semType="clnd"/><RxNorm RxCui="114202"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.30.e.3" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.30.e.1" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.30.e.0"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.30.e.2" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.30.e.0"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.30.e.2" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.30.e.1"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.30.e.3" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.30.e.1"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.30.e.3" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.30.e.2"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.57" text="If serum sodium is not rising at the desired rate, VAPRISOL may be titrated upward to 20 mg per day see Use in Specific Populations (8.6) and Clinical Pharmacology (12.3)." type="negative"><entity charOffset="9:15" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.57.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="serum sodium" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="51:59" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.57.e.1" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.57.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.57.e.1"/></sentence><sentence biomedicalEntities="0" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.58" lineNumber="53" text="CONTRAINDICATIONS SECTION" type="irregular"><entity charOffset="0:17" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.58.e.0" text="CONTRAINDICATIONS" type="Caution_Interaction"/><entity charOffset="0:17" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.58.e.2" text="CONTRAINDICATIONS" type="SPAN"/><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.58.ddi.1"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.58.e.0"><relations><relation type="hasSeverity"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.58.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.60.e.0"/></relation><relation type="hasObject"><labelDrug text="Vaprisol"/><normalization><mmtx><preferredWord>Vaprisol</preferredWord><phraseText>The coadministration of VAPRISOL</phraseText><cuiCode>C1698656</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="7" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64" lineNumber="67" text="The coadministration of VAPRISOL with potent CYP3A inhibitors, such as ketoconazole, itraconazole, clarithromycin, ritonavir, and indinavir, is contraindicated see Drug Interactions (7.1)." type="regular"><entity charOffset="24:32" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.0" text="VAPRISOL" type="Drug"><Normalization><mmtx cui="C1698656" phraseText="The coadministration of VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><entity charOffset="38:61" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.1" text="potent CYP3A inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="402226"/></Normalization></entity><entity charOffset="71:83" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.2" text="ketoconazole" type="Drug"><Normalization><mmtx cui="C0022625" phraseText="such as ketoconazole," preferredWord="Ketoconazole" semType="phsu, orch"/><RxNorm RxCui="6135"/></Normalization></entity><entity charOffset="85:97" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.3" text="itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="itraconazole," preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><entity charOffset="99:113" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.4" text="clarithromycin" type="Drug"><Normalization><mmtx cui="C0055856" phraseText="clarithromycin," preferredWord="Clarithromycin" semType="orch, antb"/><RxNorm RxCui="21212"/></Normalization></entity><entity charOffset="115:124" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.5" text="ritonavir" type="Drug"><Normalization><mmtx cui="C0292818" phraseText="ritonavir," preferredWord="Ritonavir" semType="phsu, orch"/><RxNorm RxCui="85762"/></Normalization></entity><entity charOffset="130:139" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.6" text="indinavir" type="Drug"><Normalization><mmtx cui="C0376637" phraseText="indinavir," preferredWord="Indinavir" semType="phsu, orch"/><RxNorm RxCui="114289"/></Normalization></entity><entity charOffset="144:159" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.7" text="contraindicated" type="Caution_Interaction"/><entity charOffset="144:159" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.14" text="contraindicated" type="SPAN"/><drugClassMembership drug="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.2" drugClass="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.1"/><drugClassMembership drug="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.3" drugClass="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.1"/><drugClassMembership drug="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.4" drugClass="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.1"/><drugClassMembership drug="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.5" drugClass="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.1"/><drugClassMembership drug="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.6" drugClass="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.1"/><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.ddi.1"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.1"/></relation><relation type="hasSeverity"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.14"/></relation><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.1" severity="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.14" trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.64.e.7" type="Caution_Interaction"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.66" text="Solutions containing dextrose are contraindicated in patients with known allergy to corn or corn products." type="negative"><entity charOffset="84:88" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.66.e.0" text="corn" type="Biomedical_Entity"><Normalization><mmtx cui="C1095906" phraseText="to corn" preferredWord="corn extract" semType="phsu"/><RxNorm RxCui="1323308"/></Normalization></entity><entity charOffset="21:29" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.66.e.1" text="dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="dextrose" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><entity charOffset="92:96" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.66.e.2" text="corn" type="Biomedical_Entity"><Normalization><mmtx cui="C1095906" phraseText="corn products." preferredWord="corn extract" semType="phsu"/><RxNorm RxCui="1323308"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.66.e.1" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.66.e.0"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.66.e.1" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.66.e.2"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.74" text="VAPRISOL should be used to raise serum sodium in such patients only after consideration of other treatment options see Adverse Reactions (6.1)." type="negative"><entity charOffset="39:45" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.74.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="serum sodium in such patients only" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="0:8" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.74.e.1" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.74.e.1" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.74.e.0"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.78" text="In controlled clinical trials of VAPRISOL, about 9% of patients who received VAPRISOL in doses of 20-40 mg/day IV had rises of serum sodium 12 mEq/L/24 hours, but none of these patients had evidence of osmotic demyelination or permanent neurologic sequelae. " type="negative"><entity charOffset="133:139" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.78.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="rises of serum sodium 12 mEq/L/24 hours," preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="77:85" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.78.e.1" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL in doses of 20-40 mg/day IV" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><entity charOffset="33:41" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.78.e.2" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="of VAPRISOL," preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.78.e.1" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.78.e.0"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.78.e.2" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.78.e.0"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.79" text="Serum sodium concentration and neurologic status should be monitored appropriately during VAPRISOL administration, and VAPRISOL administration should be discontinued if the patient develops an undesirably rapid rate of rise of serum sodium. " type="negative"><entity charOffset="6:12" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.79.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="Serum sodium concentration" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="90:98" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.79.e.1" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="appropriately during VAPRISOL administration," preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><entity charOffset="233:239" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.79.e.2" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="an undesirably rapid rate of rise of serum sodium." preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="119:127" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.79.e.3" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL administration" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.79.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.79.e.1"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.79.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.79.e.3"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.79.e.1" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.79.e.2"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.79.e.3" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.79.e.2"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.80" text="If the serum sodium concentration continues to rise, VAPRISOL should not be resumed. " type="negative"><entity charOffset="53:61" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.80.e.0" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><entity charOffset="13:19" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.80.e.1" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="the serum sodium concentration" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.80.e.1" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.80.e.0"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.81" text="If hyponatremia persists or recurs (after initial discontinuation of VAPRISOL for an undesirably rapid rate of rise of serum sodium concentration), and the patient has had no evidence of neurologic sequelae of rapid rise in serum sodium, VAPRISOL may be resumed at a reduced dose see Dosage and Administration (2.1)." type="negative"><entity charOffset="125:131" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.81.e.0" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="of serum sodium concentration" preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="69:77" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.81.e.1" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="of VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><entity charOffset="230:236" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.81.e.2" text="sodium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597484" phraseText="in serum sodium," preferredWord="Sodium Cation" semType="phsu, elii"/><RxNorm RxCui="1444874"/></Normalization></entity><entity charOffset="238:246" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.81.e.3" text="vaprisol" type="Biomedical_Entity"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.81.e.1" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.81.e.0"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.81.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.81.e.3"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.81.e.1" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.81.e.2"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.81.e.2" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.81.e.3"/></sentence><sentence biomedicalEntities="2" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.82" lineNumber="84" text="In clinical trials of oral conivaptan, two cases of rhabdomyolysis occurred in patients who were also receiving a CYP3A-metabolized HMG-CoA reductase inhibitor. " type="regular"><entity charOffset="22:37" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.82.e.0" text="oral conivaptan" type="Drug"><Normalization><mmtx cui="C0966107" phraseText="of oral conivaptan," preferredWord="conivaptan" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="39:48" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.82.e.1" text="two cases" type="SPAN"/><entity charOffset="52:66" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.82.e.2" text="rhabdomyolysis" type="Specific_Interaction"/><entity charOffset="114:159" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.82.e.4" text="CYP3A-metabolized HMG-CoA reductase inhibitor" type="Drug_Class"><Normalization><mmtx cui="C0360714" phraseText="a CYP3A-metabolized HMG-CoA reductase inhibitor." preferredWord="Hydroxymethylglutaryl-CoA Reductase Inhibitors" semType="phsu, orch"/><mmtx cui="C3536932" phraseText="a CYP3A-metabolized HMG-CoA reductase inhibitor." preferredWord="HMG-CoA Reductase Inhibitor [EPC]" semType="phsu"/><RxNorm RxCui="24348"/></Normalization></entity><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.82.ddi.1"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.82.e.2"><relations><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.82.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.82.e.4"/></relation><relation type="hasEvidence"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.82.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.82.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.82.e.4" evidence="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.82.e.1" trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.82.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.83" lineNumber="84" text="Avoid concomitant use of VAPRISOL with drugs eliminated primarily by CYP3A-mediated metabolism. " type="regular"><entity charOffset="0:5" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.83.e.0" text="Avoid" type="Caution_Interaction"/><entity charOffset="25:33" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.83.e.2" text="VAPRISOL" type="Drug"><Normalization><mmtx cui="C1698656" phraseText="concomitant use of VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><entity charOffset="39:94" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.83.e.3" text="drugs eliminated primarily by CYP3A-mediated metabolism" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="with drugs" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C0127400" phraseText="primarily by CYP3A-mediated metabolism." preferredWord="Mediator brand of benfluorex hydrochloride" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.83.ddi.1"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.83.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.83.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.83.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.83.e.2" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.83.e.3" trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.83.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85" lineNumber="85" text="Coadministration of digoxin with oral conivaptan resulted in a 1.8- and 1.4-fold increase in digoxin Cmax and AUC, respectively. " type="regular"><entity charOffset="33:48" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85.e.0" text="oral conivaptan" type="Drug"><Normalization><mmtx cui="C0966107" phraseText="with oral conivaptan" preferredWord="conivaptan" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="81:92|101:105" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85.e.1" text="increase in Cmax" type="Increase_Interaction"/><entity charOffset="81:92|110:113" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85.e.3" text="increase in AUC" type="Increase_Interaction"/><entity charOffset="93:100" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85.e.5" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="1.4-fold increase in digoxin Cmax" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85.ddi.1"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85.ddi.2"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85.e.5" trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.86" lineNumber="85" text="Monitor digoxin levels see Drug Interactions (7.2)." type="irregular"><entity charOffset="0:7" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.86.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="8:15" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.86.e.2" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="Monitor digoxin levels" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.86.ddi.1"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.86.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.86.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85" text="Coadministration of digoxin with oral conivaptan resulted in a 1.8- and 1.4-fold increase in digoxin Cmax and AUC, respectively. "><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.85.e.0"/></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.86.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90" lineNumber="92" text="&lt;item&gt;Potent CYP3A inhibitors may increase the exposure of conivaptan and are contraindicated (4.2, 7.1)." type="regular"><entity charOffset="6:29" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.e.0" text="Potent CYP3A inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="402226"/></Normalization></entity><entity charOffset="34:55" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.e.1" text="increase the exposure" type="Increase_Interaction"/><entity charOffset="59:69" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.e.3" text="conivaptan" type="Drug"><Normalization><mmtx cui="C0966107" phraseText="the exposure of conivaptan" preferredWord="conivaptan" semType="phsu, orch"/><RxNorm RxCui="1294548"/></Normalization></entity><entity charOffset="78:93" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.e.4" text="contraindicated" type="Caution_Interaction"/><entity charOffset="78:93" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.e.6" text="contraindicated" type="SPAN"/><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.ddi.1"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.ddi.2"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.e.3"/></relation><relation type="hasSeverity"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.e.3" trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.91" lineNumber="94" text="&lt;item&gt;Generally avoid CYP3A substrates (5.3, 7.1)." type="irregular"><entity charOffset="16:21" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.91.e.0" text="avoid" type="Caution_Interaction"/><entity charOffset="22:38" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.91.e.2" text="CYP3A substrates" type="Drug_Class"><Normalization><RxNorm RxCui="24348"/></Normalization></entity><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.91.ddi.1"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.91.e.0"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90" text="&lt;item&gt;Potent CYP3A inhibitors may increase the exposure of conivaptan and are contraindicated (4.2, 7.1)."><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.e.3"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.91.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.91.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.92" lineNumber="96" text="&lt;item&gt;Exposure to coadministered digoxin may be increased and digoxin levels should be monitored (5.4, 7.2)." type="irregular"><entity charOffset="6:14|48:57" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.92.e.0" text="Exposure increased" type="Increase_Interaction"/><entity charOffset="33:40" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.92.e.2" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="&gt;Exposure to coadministered digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.92.ddi.1"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.92.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90" text="&lt;item&gt;Potent CYP3A inhibitors may increase the exposure of conivaptan and are contraindicated (4.2, 7.1)."><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.90.e.3"/></ellipsisSentence><middleSentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.91" text="&lt;item&gt;Generally avoid CYP3A substrates (5.3, 7.1)."/></relation><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.92.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.94" text="The effect of ketoconazole, a potent CYP3A inhibitor, on the pharmacokinetics of intravenous conivaptan has not been evaluated. " type="negative"><entity charOffset="14:26" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.94.e.0" text="ketoconazole" type="Biomedical_Entity"><Normalization><mmtx cui="C0022625" phraseText="The effect of ketoconazole," preferredWord="Ketoconazole" semType="phsu, orch"/><RxNorm RxCui="6135"/></Normalization></entity><entity charOffset="93:103" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.94.e.1" text="conivaptan" type="Biomedical_Entity"><Normalization><mmtx cui="C0966107" phraseText="of intravenous conivaptan" preferredWord="conivaptan" semType="phsu, orch"/><RxNorm RxCui="1294548"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.94.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.94.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95" lineNumber="99" text="Coadministration of oral conivaptan hydrochloride 10 mg with ketoconazole 200 mg resulted in 4- and 11-fold increases in Cmax and AUC of conivaptan, respectively see Contraindications (4.2)." type="regular"><anaphoraRelation><anaphoraEntity charOffset="137:147" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.e.6" text="conivaptan" type="Drug"/><antecedentEntity charOffset="20-49" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.e.0" text="oral conivaptan hydrochloride" type="Drug"/></anaphoraRelation><entity charOffset="20:49" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.e.0" text="oral conivaptan hydrochloride" type="Drug"><Normalization><mmtx cui="C1700196" phraseText="Coadministration of oral conivaptan hydrochloride 10 mg" preferredWord="Conivaptan hydrochloride" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="61:73" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.e.1" text="ketoconazole" type="Drug"><Normalization><mmtx cui="C0992485" phraseText="with ketoconazole 200 mg" preferredWord="Ketoconazole 200 MG" semType="clnd"/><RxNorm RxCui="6135"/></Normalization></entity><entity charOffset="108:125" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.e.2" text="increases in Cmax" type="Increase_Interaction"/><entity charOffset="108:120|130:133" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.e.4" text="increases in AUC" type="Increase_Interaction"/><entity charOffset="137:147" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.e.6" text="conivaptan" type="Drug"><Normalization><mmtx cui="C0966107" phraseText="AUC of conivaptan," preferredWord="conivaptan" semType="phsu, orch"/><RxNorm RxCui="1294548"/></Normalization></entity><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.ddi.1"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.ddi.2"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.e.1" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.e.6" trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.95.e.2" type="Increase_Interaction"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97" text="The effect of conivaptan on the pharmacokinetics of co-administered CYP3A substrates has been evaluated with the coadministration of conivaptan with midazolam, simvastatin, and amlodipine. " type="negative"><entity charOffset="149:158" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.0" text="midazolam" type="Biomedical_Entity"><Normalization><mmtx cui="C0026056" phraseText="with midazolam," preferredWord="Midazolam" semType="phsu, orch"/><RxNorm RxCui="203128"/></Normalization></entity><entity charOffset="177:187" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.1" text="amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0051696" phraseText="amlodipine." preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="160:171" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.2" text="simvastatin" type="Biomedical_Entity"><Normalization><mmtx cui="C0074554" phraseText="simvastatin," preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><entity charOffset="133:143" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.3" text="conivaptan" type="Biomedical_Entity"><Normalization><mmtx cui="C0966107" phraseText="evaluated with the coadministration of conivaptan" preferredWord="conivaptan" semType="phsu, orch"/><RxNorm RxCui="1294548"/></Normalization></entity><entity charOffset="14:24" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.4" text="conivaptan" type="Biomedical_Entity"><Normalization><mmtx cui="C0966107" phraseText="The effect of conivaptan" preferredWord="conivaptan" semType="phsu, orch"/><RxNorm RxCui="1294548"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.1"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.2"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.3" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.0"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.4" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.0"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.2" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.1"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.3" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.1"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.4" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.1"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.3" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.2"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.4" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.97.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.98" lineNumber="100" text="VAPRISOL 40 mg/day increased the mean AUC values by approximately 2- and 3-fold for 1 mg intravenous or 2 mg oral doses of midazolam, respectively. " type="regular"><entity charOffset="0:8" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.98.e.0" text="VAPRISOL" type="Drug"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL 40 mg/day" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><entity charOffset="19:48" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.98.e.1" text="increased the mean AUC values" type="Increase_Interaction"/><entity charOffset="89:100|123:132" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.98.e.3" text="intravenous midazolam" type="Drug"><Normalization><mmtx cui="C2346927" phraseText="2 mg oral doses of midazolam," preferredWord="Magnesium Cation" semType="phsu, elii"/><mmtx cui="C0026056" phraseText="2 mg oral doses of midazolam," preferredWord="Midazolam" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="109:132" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.98.e.4" text="oral doses of midazolam" type="Drug"><Normalization><mmtx cui="C0026056" phraseText="2 mg oral doses of midazolam," preferredWord="Midazolam" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.98.ddi.1"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.98.e.1"><relations><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.98.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.98.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.98.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.98.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.98.e.4" trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.98.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.98.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.98.e.3" trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.98.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.99" lineNumber="100" text="VAPRISOL 30 mg/day resulted in a 3-fold increase in the AUC of simvastatin. " type="regular"><entity charOffset="0:8" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.99.e.0" text="VAPRISOL" type="Drug"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL 30 mg/day" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><entity charOffset="40:59" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.99.e.1" text="increase in the AUC" type="Increase_Interaction"/><entity charOffset="63:74" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.99.e.3" text="simvastatin" type="Drug"><Normalization><mmtx cui="C0074554" phraseText="of simvastatin." preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.99.ddi.1"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.99.e.1"><relations><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.99.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.99.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.99.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.99.e.3" trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.99.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.100" lineNumber="100" text="Oral conivaptan hydrochloride 40 mg twice daily resulted in a 2-fold increase in the AUC and half-life of amlodipine see Warnings and Precautions (5.3)." type="regular"><entity charOffset="0:29" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.100.e.0" text="Oral conivaptan hydrochloride" type="Drug"><Normalization><mmtx cui="C1700196" phraseText="Oral conivaptan hydrochloride 40 mg twice daily" preferredWord="Conivaptan hydrochloride" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="69:88" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.100.e.1" text="increase in the AUC" type="Increase_Interaction"/><entity charOffset="69:84|93:102" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.100.e.3" text="increase in the half-life" type="Increase_Interaction"/><entity charOffset="106:116" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.100.e.5" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="half-life of amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.100.ddi.1"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.100.e.1"><relations><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.100.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.100.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.100.ddi.2"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.100.e.3"><relations><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.100.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.100.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.100.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.100.e.5" trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.100.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101" lineNumber="101" text="Coadministration of a 0.5 mg dose of digoxin, a P-glycoprotein substrate, with oral conivaptan hydrochloride 40 mg twice daily resulted in a 30% reduction in clearance and 79% and 43% increases in digoxin Cmax and AUC values, respectively see Warnings and Precautions (5.4)." type="regular"><entity charOffset="37:44" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.0" text="digoxin" type="Drug"><Normalization><mmtx cui="C0992262" phraseText="Coadministration of a 0.5 mg dose of digoxin," preferredWord="Digoxin 0.5 MG" semType="clnd"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="48:72" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.1" text="P-glycoprotein substrate" type="Drug_Class"><Normalization><RxNorm RxCui="32760"/></Normalization></entity><entity charOffset="79:108" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.3" text="oral conivaptan hydrochloride" type="Drug"><Normalization><mmtx cui="C1700196" phraseText="with oral conivaptan hydrochloride 40 mg twice daily" preferredWord="Conivaptan hydrochloride" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="145:167" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.4" text="reduction in clearance" type="Increase_Interaction"/><entity charOffset="184:196|205:209" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.6" text="increases in Cmax" type="Increase_Interaction"/><entity charOffset="184:196|214:217" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.8" text="increases in AUC" type="Increase_Interaction"/><entity charOffset="197:204" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.10" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="43% increases in digoxin Cmax" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><drugClassMembership drug="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.0" drugClass="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.1"/><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.ddi.1"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.ddi.2"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.6"><relations><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.10"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.ddi.3"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.8"><relations><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.10"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.3" trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.4" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.3" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.10" trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.101.e.6" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102" lineNumber="102" text="VAPRISOL (40 mg/day for 4 days) administered with a single 25 mg dose of warfarin, which undergoes major metabolism by CYP2C9 and minor metabolism by CYP3A, increased the mean S-warfarin AUC and S-warfarin Cmax by 14% and 17%, respectively. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="176:186" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.5" text="S-warfarin" type="Drug"/><antecedentEntity charOffset="73-81" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.7" text="warfarin" type="Drug"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="195:205" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.6" text="S-warfarin" type="Drug"/><antecedentEntity charOffset="73-81" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.7" text="warfarin" type="Drug"/></anaphoraRelation><entity charOffset="0:8" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.0" text="VAPRISOL" type="Drug"><Normalization><mmtx cui="C1698656" phraseText="VAPRISOL" preferredWord="Vaprisol" semType="phsu, orch"/><RxNorm RxCui="616622"/></Normalization></entity><entity charOffset="157:175|187:190" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.1" text="increased the mean AUC" type="Increase_Interaction"/><entity charOffset="157:175|206:210" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.3" text="increased the mean Cmax" type="Increase_Interaction"/><entity charOffset="176:186" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.5" text="S-warfarin" type="Drug"><Normalization><mmtx cui="C0043031" phraseText="warfarin AUC" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="195:205" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.6" text="S-warfarin" type="Drug"><Normalization><mmtx cui="C0043031" phraseText="warfarin Cmax by 14%" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="73:81" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.7" text="warfarin" type="Drug"><Normalization><mmtx cui="C0043031" phraseText="administered with a single 25 mg dose of warfarin," preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.ddi.1"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.ddi.2"><interaction trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.3"><relations><relation type="hasPrecipitant"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.5" trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.6" trigger="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.102.e.3" type="Increase_Interaction"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.104" text="The pharmacokinetics of oral conivaptan (20 - 40 mg/day) were unchanged with coadministration of either captopril 25 mg or furosemide up to 80 mg/day." type="negative"><entity charOffset="123:145" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.104.e.0" text="furosemide 80 mg" type="Biomedical_Entity"><Normalization><mmtx cui="C0992359" phraseText="furosemide up to 80 mg/day." preferredWord="Furosemide 80 MG" semType="clnd"/><RxNorm RxCui="4603"/></Normalization></entity><entity charOffset="104:119" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.104.e.1" text="captopril 25 mg" type="Biomedical_Entity"><Normalization><mmtx cui="C0984502" phraseText="unchanged with coadministration of either captopril 25 mg" preferredWord="Captopril 25 MG" semType="clnd"/><RxNorm RxCui="1998"/></Normalization></entity><entity charOffset="29:39" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.104.e.2" text="conivaptan" type="Biomedical_Entity"><Normalization><mmtx cui="C0966107" phraseText="The pharmacokinetics of oral conivaptan" preferredWord="conivaptan" semType="phsu, orch"/><RxNorm RxCui="1294548"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.104.e.1" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.104.e.0"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.104.e.2" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.104.e.0"/><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.104.e.2" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.104.e.1"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.108" text="&lt;item&gt;Conivaptan hydrochloride is a white to off-white or pale orange-white powder that is very slightly soluble in water (0.15 mg/mL at 23 C). " type="negative"><entity charOffset="131:139" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.108.e.0" text="ml 23" type="Biomedical_Entity"><Normalization><mmtx cui="C0066650" phraseText="(0.15 mg/mL at 23 C)." preferredWord="ML 23" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="6:30" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.108.e.1" text="conivaptan hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C1700196" phraseText="&gt;Conivaptan hydrochloride" preferredWord="Conivaptan hydrochloride" semType="phsu, orch"/><RxNorm RxCui="1294548"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.108.e.1" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.108.e.0"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.109" text="Conivaptan hydrochloride injection is supplied as a sterile premixed solution with dextrose in a flexible plastic container." type="negative"><entity charOffset="0:24" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.109.e.0" text="conivaptan hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C1700196" phraseText="Conivaptan hydrochloride injection" preferredWord="Conivaptan hydrochloride" semType="phsu, orch"/><RxNorm RxCui="1294548"/></Normalization></entity><entity charOffset="83:91" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.109.e.1" text="dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="with dextrose" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.109.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.109.e.1"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.110" text="&lt;item&gt;Each container contains a clear, colorless, sterile, non-pyrogenic solution of conivaptan hydrochloride in dextrose. " type="negative"><entity charOffset="85:109" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.110.e.0" text="conivaptan hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C1700196" phraseText="a clear, colorless, sterile, non-pyrogenic solution of conivaptan hydrochloride" preferredWord="Conivaptan hydrochloride" semType="phsu, orch"/><RxNorm RxCui="1294548"/></Normalization></entity><entity charOffset="113:121" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.110.e.1" text="dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="in dextrose." preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.110.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.110.e.1"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.111" text="Each 100 mL, single-use premixed INTRAVIA Container contains 20 mg of conivaptan hydrochloride and 5 g of Dextrose Hydrous, USP. " type="negative"><entity charOffset="70:94" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.111.e.0" text="conivaptan hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C1700196" phraseText="20 mg of conivaptan hydrochloride" preferredWord="Conivaptan hydrochloride" semType="phsu, orch"/><RxNorm RxCui="1294548"/></Normalization></entity><entity charOffset="99:114" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.111.e.1" text="5 dextrose" type="Biomedical_Entity"><Normalization><mmtx cui="C0985452" phraseText="5 g of Dextrose Hydrous, USP." preferredWord="Glucose 50 MG/ML" semType="clnd"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.111.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.111.e.1"/></sentence><sentence id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.112" text="Lactic Acid, USP is added for pH adjustment to pH 3.4 to 3.8. " type="negative"><entity charOffset="0:11" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.112.e.0" text="lactic acid" type="Biomedical_Entity"><Normalization><mmtx cui="C0064582" phraseText="Lactic Acid," preferredWord="Lactic acid" semType="bacs, phsu, orch"/><RxNorm RxCui="28393"/></Normalization></entity><entity charOffset="47:51" id="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.112.e.1" text="ph 3" type="Biomedical_Entity"><Normalization><mmtx cui="C0601906" phraseText="to pH 3.4" preferredWord="PH.3" semType="phsu"/><RxNorm RxCui="216597"/></Normalization></entity><pair ddi="false" e1="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.112.e.0" e2="Dailymed.87713d73-5dcc-4158-8890-60efdbd28c05.s.112.e.1"/></sentence><positiveExamples number="16"/><negativeExamples number="55"/></document>